We are constantly innovating our people, project management and technology models leading to outstanding results for our collaborators. The world’s first app based technology platform Chemistry in the CloudTM enables us to work together to make faster decisions. Our deep understanding that an early and intensive evaluation of target molecules based on real insight into the science will lead to faster downstream execution. The result is a higher throughput of successful drug-like compounds.
We are extremely delighted to announce that one of the o2h Ventures Limited portfolio companies @ExonateUK has anno… https://t.co/Sr7aMnCtPi
Walk-in Interview at Noida on the 4th January 2020!
We have exciting opportunities for Chemists and Research analys… https://t.co/udePDBs8wq
o2h family wishes you a very happy new year!
#2020NewYear #NewYearsDay #HappyNewDecade #o2hlife https://t.co/CkQ0lDieDV
Thank you @prashantshah123, Executive Chairman of o2h group, for being our secret Santa on the eve, we really enjoy… https://t.co/AS8qlfSEw2
RT @UKBAngels: It was great to have our Angel of the Year and @o2hventures CEO Sunil Shah with us at Future Forward last month, he also wro…
RT @MarkEISADG: .@UKI2S, @gmclifesciences and Jonathan Milner invest £500k in gene modification technology company Pencil Biosciences. Furt…
It was great to see so many of our friends and collaborators make it through the freezing weather to meet with us a… https://t.co/1EoEvPTbJ7
RT @iitoLifeScience: UKI2S, Catapult Ventures & Jonathan Milner Invest £500K in Gene Modulation Newcomer Pencil Biosciences https://t.co/Br …
Join us for a pint at our 4th Cambridge squaredTM event tomorrow!
#o2hdiscovery #CambridgesqauredTM #biology… https://t.co/q2rCVyMXJ7